Review on zolgensma

Abstract

Disease and disorders are outlined as disablement of the normal state of living organism and annoyance of normal functioning of the body respectively. The ideal causes of the disorders are genetic factors, disease, stress or trauma. Genetic disorders are a pathological state provoked by one or more monstrosities in the genome. Spinal Muscular Atrophy is a rare genetic disease and most common monogenic cause of infant mortality. Hypotonia and weakness are most common manifestations of Spinal Muscular Atrophy delineated by degeneration of anterior horn cells of the spinal cord. SMA is originated due to mutations and deletions of SMN1 (Survival Motor Neuron) gene on Chromosome 5q. Disease modifying therapy and Gene replacing therapy are the common gene therapy used to treat genetic disorders. Zolgensma is an Adeno virus associated gene therapy restored a gene which is functional one. Children under the age of 2 are benefited from a single time intravenous (IV) infusion of Zolgensma. In future Gene therapy can treat all the illness associated with Genetic disorders.